112 related articles for article (PubMed ID: 38706059)
1. [Study on the inhibitory and pro-apoptotic effects of different concentrations of total tanshinone alone and in combination with tyrosine kinase inhibitors on human myeloid leukemia cell lines].
Zhou XS; Fang JC; Ma XL; Zhang Y; Wang F; Chen X; Wu QS; Cao PX; Liu HX
Zhonghua Yi Xue Za Zhi; 2024 May; 104(17):1514-1520. PubMed ID: 38706059
[No Abstract] [Full Text] [Related]
2. [Reversal Effect of Arctigenin on the Drug Resistance in Leukemia K562/A02 Cells and Its Mechanism].
Zou L; Fang Y; He W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):409-415. PubMed ID: 38660844
[TBL] [Abstract][Full Text] [Related]
3. [Effect of tanshinone II A on leukemia cell line K562].
Shan QQ; Guo Y; Gong YP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):410-3. PubMed ID: 24941807
[TBL] [Abstract][Full Text] [Related]
4. [Effect of Curcumin on the Proliferation, Apoptosis, and Cell Cycle of Human Acute Myeloid Leukemia Cell Line K562].
Li YY; Liu HC; Zhang Q; Feng RT; Song YS; Ming L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1343-1347. PubMed ID: 36208233
[TBL] [Abstract][Full Text] [Related]
5. Growth-inhibitory and apoptosis-inducing effects of tanshinones on hematological malignancy cells and their structure-activity relationship.
Li H; Zhang Q; Chu T; Shi HY; Fu HM; Song XR; Meng WT; Mao SJ; Jia YQ
Anticancer Drugs; 2012 Sep; 23(8):846-55. PubMed ID: 22495618
[TBL] [Abstract][Full Text] [Related]
6. [Effects of matrine combined with LY294002 on proliferation, apoptosis and cell cycle of human myeloid leukemia K562 cells].
Hao Y; Ji J; Liu C; Zhang N; Gong Y
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Nov; 42(11):1739-1746. PubMed ID: 36504069
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X
Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223
[TBL] [Abstract][Full Text] [Related]
8. A molecular and biophysical comparison of macromolecular changes in imatinib-sensitive and imatinib-resistant K562 cells exposed to ponatinib.
Yandim MK; Ceylan C; Elmas E; Baran Y
Tumour Biol; 2016 Feb; 37(2):2365-78. PubMed ID: 26373734
[TBL] [Abstract][Full Text] [Related]
9. Effects of Thalidomide Combined with Interferon on Inhibiting Kasumi-1 Cell Proliferation.
Xu H; Mi R; Fan R; Yin Q; Wei X
Adv Clin Exp Med; 2016; 25(3):403-8. PubMed ID: 27629726
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA inhibits leukemia THP-1 cell growth by induction of apoptosis.
Liu JJ; Zhang Y; Lin DJ; Xiao RZ
Oncol Rep; 2009 Apr; 21(4):1075-81. PubMed ID: 19288011
[TBL] [Abstract][Full Text] [Related]
11. Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells via PPP2R5C down-regulation.
Shen Q; Liu S; Chen Y; Yang L; Chen S; Wu X; Li B; Lu Y; Zhu K; Li Y
J Hematol Oncol; 2013 Sep; 6():64. PubMed ID: 24004697
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic effect and apoptotic mechanism of tanshinone A, a novel tanshinone derivative, on human erythroleukemic K562 cells.
Zhen X; Cen J; Li YM; Yan F; Guan T; Tang XZ
Eur J Pharmacol; 2011 Sep; 667(1-3):129-35. PubMed ID: 21699893
[TBL] [Abstract][Full Text] [Related]
13. Persistent STAT5-mediated ROS production and involvement of aberrant p53 apoptotic signaling in the resistance of chronic myeloid leukemia to imatinib.
Cheng Y; Hao Y; Zhang A; Hu C; Jiang X; Wu Q; Xu X
Int J Mol Med; 2018 Jan; 41(1):455-463. PubMed ID: 29115375
[TBL] [Abstract][Full Text] [Related]
14. PIM-1 kinase inhibitor SMI-4a exerts antitumor effects in chronic myeloid leukemia cells by enhancing the activity of glycogen synthase kinase 3β.
Fan RF; Lu Y; Fang ZG; Guo XY; Chen YX; Xu YC; Lei YM; Liu KF; Lin DJ; Liu LL; Liu XF
Mol Med Rep; 2017 Oct; 16(4):4603-4612. PubMed ID: 28849186
[TBL] [Abstract][Full Text] [Related]
15. [Effects of STI571 combined with As₂O₃ on proliferation, apoptosis and caspase 3, Bcl-xL expression of K562 cells].
Chen NY; Wang J; Wang XM; Zhang HX; Yan ZY; Wang YM; Zhang S; Yan B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):882-6. PubMed ID: 20723293
[TBL] [Abstract][Full Text] [Related]
16. [Alteration of activities of telomerase in tanshinone IIA inducing apoptosis of the leukemia cells].
Song Y; Yuan SL; Yang YM; Wang XJ; Huang GQ
Zhongguo Zhong Yao Za Zhi; 2005 Feb; 30(3):207-11. PubMed ID: 15719642
[TBL] [Abstract][Full Text] [Related]
17. Curcumin derivative C817 inhibits proliferation of imatinib-resistant chronic myeloid leukemia cells with wild-type or mutant Bcr-Abl in vitro.
Wu LX; Wu Y; Chen RJ; Liu Y; Huang LS; Lou LG; Zheng ZH; Chen YZ; Xu JH
Acta Pharmacol Sin; 2014 Mar; 35(3):401-9. PubMed ID: 24487968
[TBL] [Abstract][Full Text] [Related]
18. [Effect of Hispidulin on Proliferation and Apoptosis of Leukemia K562 Cells by Up-Regulating IL-37].
Tang H; Sun H; Yang FF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1322-1326. PubMed ID: 37846679
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of Paris Forrestii (Takht.) H. Li-Suppressing the Proliferation of Acute Myeloid Leukemia Cell Lines].
Lu Q; Zheng YJ; Hu YX; Wang YH; Mao XL; Hu SY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):7-13. PubMed ID: 30738440
[TBL] [Abstract][Full Text] [Related]
20. The Critical Role of PTEN/PI3K/AKT Signaling Pathway in Shikonin-Induced Apoptosis and Proliferation Inhibition of Chronic Myeloid Leukemia.
Chen Y; Wang T; Du J; Li Y; Wang X; Zhou Y; Yu X; Fan W; Zhu Q; Tong X; Wang Y
Cell Physiol Biochem; 2018; 47(3):981-993. PubMed ID: 29843123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
